A review of clinical guidelines, laboratory recommendations and external quality assurance programs for monoclonal gammopathy testing.

Lim, Say Min; Wijeratne, Nilika; Choy, Kay Weng; Nguyen, Thi Thanh Hai; Setiawan, Lyana; Loh, Tze Ping

Lim, Say Min; Wijeratne, Nilika; Choy, Kay Weng; Nguyen, Thi Thanh Hai; Setiawan, Lyana; Loh, Tze Ping.

Affiliation

Lim SM; Sarawak General Hospital, Sarawak, Malaysia.
Wijeratne N; Dorevitch Pathology, Melbourne, Australia.
Choy KW; School of Clinical Sciences at Monash Health, Department of Medicine, Nursing and Health Sciences, Monash University, Clayton, Australia.
Nguyen TTH; Eastern Health Pathology, Eastern Health, Box Hill, Australia.
Setiawan L; Dorevitch Pathology, Heidelberg, Australia.
Loh TP; Northern Health, Epping, Australia.

Crit Rev Clin Lab Sci ; 61(2): 107-126, 2024 Mar.

Article in En | MEDLINE | ID: mdl-37776896

Subject(s)

Monoclonal Gammopathy of Undetermined Significance; Paraproteinemias; Humans; Monoclonal Gammopathy of Undetermined Significance/diagnosis; Paraproteinemias/diagnosis; Laboratories; Immunoglobulin Light Chains

Key words

Protein electrophoresis; monoclonal gammopathy; multiple myeloma; quality assurance

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Paraproteinemias / Monoclonal Gammopathy of Undetermined Significance Type of study: Guideline Limits: Humans Language: En Journal: Crit Rev Clin Lab Sci Journal subject: TECNICAS E PROCEDIMENTOS DE LABORATORIO Year: 2024 Type: Article Affiliation country: Malaysia

Fulltext

XML

PubMed Links

Search on Google